EUVIMEDEUVIMED entdecken
Crossref

Cardiac Reoperation or Transcatheter Mitral Valve Replacement for Patients With Failed Mitral Prostheses

Hiroki A Ueyama, Yoshihisa Miyamoto, Atsuyuki Watanabe, Hiroshi Gotanda, Stamatios Lerakis, Azeem Latib, Tsuyoshi Kaneko, Toshiki Kuno, Yusuke Tsugawa

Journal of the American College of Cardiology · 2024

DOI: 10.1016/j.jacc.2023.10.014 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American College of Cardiology, 2024. Verfasst von Hiroki A Ueyama und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Emory University School of Medicine, Atlanta, Georgia, USA. Hauptthemen laut MEDLINE: Mitral Valve Insufficiency, Heart Valve Prosthesis Implantation. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: NIA NIH HHS, NIMHD NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Evidence is limited regarding patient outcomes comparing redo surgical mitral valve replacement (redo SMVR) vs transcatheter mitral valve replacement (TMVR) for failed prostheses. OBJECTIVES: The goal of this study was to compare the outcomes of redo SMVR vs TMVR in patients with failed prostheses, as well as evaluate the association between case volume and outcomes. METHODS: Medicare beneficiaries aged ≥65 years who underwent redo SMVR or TMVR for failed mitral prostheses between 2016 and 2020 were included. The primary endpoint was mid-term (up to 3 years) major adverse cardiovascular events (MACE), including all-cause death, heart failure rehospitalization, stroke, or reintervention. Propensity score-matched analysis was used. RESULTS: A total of 4,293 patients were included (redo SMVR: 64%; TMVR: 36%). TMVR recipients were older, with a higher comorbidity burden. In matched cohort (n = 1,317 in each group), mid-term risk of MACE was similar (adjusted HR: 0.92; 95% CI: 0.80-1.04; P = 0.2). However, landmark analysis revealed a lower risk of MACE with TMVR in the first 6 months (adjusted HR: 0.75; 95% CI: 0.63-0.88; P < 0.001) albeit with a higher risk beyond 6 months (adjusted HR: 1.28; 95% CI: 1.04-1.58; P = 0.02). Increasing procedural volume was associated with decreased risk of mid-term MACE after redo SMVR (P = 0.001) but not after TMVR (P = 0.3). CONCLUSIONS: In this large cohort of Medicare beneficiaries with failed mitral prostheses, outcomes were similar between redo SMVR and TMVR at 3 years, with TMVR showing a lower initial risk but a higher risk of MACE after 6 months. These findings highlight the importance of striking a balance between surgical risk, anticipated longevity, and hospital expertise when selecting interventions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mitral Valve InsufficiencyHeart Valve Prosthesis ImplantationHumansAgedUnited StatesMitral ValveReoperationCardiac CatheterizationMedicareProstheses and ImplantsTreatment Outcome

Stichwörter der Autor:innen

mitral valve prosthesesmitral valve replacementprocedural volumeprosthetic mitral regurgitationprosthetic mitral stenosisredo surgical mitral valve replacementtranscatheter mitral valve replacement

Autor:innen und Institutionen

  • Division of Cardiology, Emory University School of Medicine, Atlanta, Georgia, USA.
  • Division of Nephrology and Endocrinology, The University of Tokyo Hospital, Tokyo, Japan.
  • Department of Medicine, Icahn School of Medicine at Mount Sinai, Mount Sinai Beth Israel, New York, New York, USA.
  • Division of General Internal Medicine, Cedars-Sinai Medical Center, Los Angeles, California, USA.
  • Division of Cardiology, Icahn School of Medicine at Mount Sinai, Mount Sinai Hospital, New York, New York, USA.
  • Division of Cardiology, Montefiore Medical Center, Albert Einstein College of Medicine, New York, New York, USA.

Förderung

  • NIA NIH HHS
  • NIMHD NIH HHS

Zitieren

APA

Ueyama, H. A., Miyamoto, Y., Watanabe, A., Gotanda, H., Lerakis, S., Latib, A., Kaneko, T., Kuno, T., & Tsugawa, Y. (2024). Cardiac Reoperation or Transcatheter Mitral Valve Replacement for Patients With Failed Mitral Prostheses. Journal of the American College of Cardiology. https://doi.org/10.1016/j.jacc.2023.10.014

Vancouver

Ueyama HA, Miyamoto Y, Watanabe A, Gotanda H, Lerakis S, Latib A, et al. Cardiac Reoperation or Transcatheter Mitral Valve Replacement for Patients With Failed Mitral Prostheses. Journal of the American College of Cardiology. 2024. doi:10.1016/j.jacc.2023.10.014

BibTeX
@article{Ueyama2024,
  author = {Ueyama, Hiroki A and Miyamoto, Yoshihisa and Watanabe, Atsuyuki and Gotanda, Hiroshi and Lerakis, Stamatios and Latib, Azeem and Kaneko, Tsuyoshi and Kuno, Toshiki and Tsugawa, Yusuke},
  title = {Cardiac Reoperation or Transcatheter Mitral Valve Replacement for Patients With Failed Mitral Prostheses},
  journal = {Journal of the American College of Cardiology},
  year = {2024},
  doi = {10.1016/j.jacc.2023.10.014}
}
Kostenlos starten →